sodium ferric gluconate

DRUG2 trials

Sponsors

Sanofi, University of North Carolina, Chapel Hill

Conditions

AnemiaHeart FailureIron Deficiency Anemia

Phase 4

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

TerminatedNCT00223938

Start: 2003-12-30End: 2007-04-27Updated: 2021-06-24

Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure

CompletedNCT01925703

University of North Carolina, Chapel HillHeart Failure, Iron Deficiency Anemia

Start: 2011-04-30End: 2013-12-31Updated: 2015-08-25